Novel piperidyl indolinone compounds are provided that are useful as agonist and antagonist ligands of the nociceptin receptor. The compounds are useful to treat a variety of disorders, and are particularly useful as analgesics

 
Web www.patentalert.com

< Substituted heteroaryl- and phenylsulfamoyl compounds

< Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods

> Tetrahydro-indazole cannabinoid modulators

> 11-Beta hydroxysteroid dehydrogenase type 1 inhibitors as anti-obesity/anti-diabetes compounds and 17-beta hydrosteroid dehydrogenase type I inhibitors as useful agents for the treatment of cancers, especially breast cancer

~ 00214